After a genetic assessment, 69% (30/43) met criteria for genetic testing, which comprised of 56.6% (17/30) breast cancer panel tests, 36.6% (11/30) BRCA1/2 only tests and 6.6% (2/30) predictive tests. The gene discussed is BRCA1; the disease is breast carcinoma.